Autolus Therapeutics (AUTL) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to -$0.30.
- Autolus Therapeutics' EPS (Weighted Average and Diluted) rose 3.23% to -$0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year increase of 31.97%. This contributed to the annual value of -$0.86 for FY2024, which is 28.33% up from last year.
- As of Q3 2025, Autolus Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.30, which was down 66.67% from -$0.18 recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$0.07 during Q4 2021, and its lowest value of -$445.41 during Q3 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.25, with a median of -$0.26 in 2025.
- Per our database at Business Quant, Autolus Therapeutics' EPS (Weighted Average and Diluted) slumped by 43,642.41% in 2021 and then skyrocketed by 99.89% in 2022.
- Over the past 5 years, Autolus Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.07 in 2021, then tumbled by 229.83% to -$0.23 in 2022, then slumped by 95.65% to -$0.45 in 2023, then skyrocketed by 80.00% to -$0.09 in 2024, then increased by 3.23% to -$0.30 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.30 in Q3 2025, compared to -$0.18 in Q2 2025 and -$0.26 in Q1 2025.